Plasmapheresis and Immunosuppressive Drug Therapy in Myasthenia Gravis

New England Journal of Medicine

Volumn 297, Issue 21, 1977, Pages 1134-1140

  Dau, Peter C ^a   Lindstrom, Jon M ^a   Cassel, Christine K ^a   Denys, Eric H ^a   Shev, Edward E ^a   Spitler, Lynn E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CHOLINERGIC RECEPTOR; PREDNISONE;

CENTRAL NERVOUS SYSTEM; DRUG THERAPY; IMMUNOSUPPRESSIVE TREATMENT; MYASTHENIA GRAVIS; PLASMAPHERESIS; THERAPY; THYMECTOMY;

EID: 0017606132     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197711242972102     Document Type: Article

References (34)

1. Mann JD, Johns TR, Campa JF: Long-term administration of corticosteroids in myasthenia gravis. Neurology (Minneap) 26: 729–740, 1976
2. Brunner NG, Berger CL, Namba T, et al: Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management. Ann NY Acad Sci 274: 577–595, 1976
3. Mertens H-G, Hertel G: Immunodepressive Behandlung der Myasthenia. Med Welt 24: 955–963, 1973
4. Matell G, Bergström K, Franksson C, et al: Effects of some immunosuppressive procedures on myasthenia gravis. Ann NY Acad Sci 274: 659–676, 1976
5. Papatestas AE, Alpert LI, Osserman K.E, et al: Studies in myasthenia gravis: effects of thymectomy: results on 185 patients with nonthymomatous myasthenia gravis, 1941–1969. Am J Med 50: 465–474, 1971
6. Genkins G, Papatestas AE, Horowitz SH, et al: Studies in myasthenia gravis: early thymectomy: electrophysiologic and pathologic correlations. Am J Med 58: 517–524, 1975
7. Engel AG, Santa T: Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome. Ann NY Acad Sci 183: 46–63, 1971
8. Fambrough D, Drachman DB, Satyamurti S: Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science 182: 293–295, 1973
9. Engel AG, Lindstrom JM, Lambert EH, et al: Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Neurology (Minneap) 27: 307–315, 1977
10. Lindstrom JM, Lambert EH: Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis and in Eaton-Lambert syndrome. Neurology (in press)
11. Patrick J, Lindstrom JM: Autoimmune response to acetylcholine receptor. Science 180: 871–872, 1973
12. Engel AG, Tsujihata M, Lambert EH, et al: Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations. J Neuropathol Exp Neurol 35: 569–587, 1976
13. Lindstrom JM, Einarson BL, Lennon VA, et al: Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental autoimmune myasthenia gravis. J Exp Med 144: 726–738, 1976
14. Engel AG, Lambert EH, Howard FM Jr: Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc 52: 267–280, 1977
15. Toyka KV, Drachman DB, Griffin DE, et al: Myasthenia gravis: study of humoral immune mechanisms by passive transfer to mice. N Engl J Med 296: 125–131, 1977
16. Lindstrom JM, Engel AG, Seybold ME, et al: Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with antiacetylcholine receptor antibodies. J Exp Med 144: 739–753, 1976
17. Lindstrom JM, Seybold MD, Lennon VA, et al: Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. Neurology (Minneap) 26: 1054–1059, 1976
18. Keesey J, Lindstrom J, Cokely H, et al: Anti-acetylcholine receptor antibody in neonatal myasthenia gravis. N Engl J Med 296: 55, 1977
19. Tindall SC, Peters BH, Caverly JR, et al: Thoracic duct depletion in myasthenia gravis. Arch Neurol 29: 202–203, 1973
20. Dunn JM: Neonatal myasthenia. Am J Obstet Gynecol 125: 265–266, 1976
21. Lockwood CM, Rees AJ, Pearson TA, et al: Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet 1: 711–715, 1976
22. Pinching AJ, Peters DK, Davis JN: Remission of myasthenia gravis following plasma-exchange. Lancet 2: 1373–1376, 1976
23. Finn R, Coates PM: Plasma exchange in myasthenia gravis. Lancet 1: 190–191, 1977
24. Osserman KE: Myasthenia Gravis. New York, Grune & Stratton, 1958
25. Lindstrom J: An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathol 7: 36–43, 1977
26. Brumlik J: Myasthenia gravis associated with wasp sting. JAMA 235: 2120–2121, 1976
27. Dutton RW, Mischell RI: Cellular events in the immune response: the in vitro response of normal spleen cells to erythrocyte antigens. Cold Spring Harbor Symp Quant Biol 32: 407–414, 1967
28. Sturgill BC, Worzniak MJ: Stimulation of proliferation of 19S antibody-forming cells in the spleens of immunized guinea-pigs after exchange transfusion. Nature 228: 1304–1305, 1970
29. Bystryn J-C, Graf MW, Uhr JW: Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion. J Exp Med 132: 1279–1287, 1970
30. Branda RF, Moldow CF, McCullough JJ, et al: Plasma exchange in the treatment of immune disease. Transfusion 15: 570–576, 1975
31. Bystryn JC, Schenkein I, Uhr JW: A model for the regulation of antibody synthesis by serum antibody, Progress in Immunology I. Edited by B Amos. New York, Academic Press, 1971, pp 628–637
32. McMillan R, Longmire R, Yelenosky R: The effect of corticosteroids on human IgG synthesis. J Immunol 116: 1592–1595, 1976
33. Fauci AS, Dale DC, Balow JE: Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 84: 304–315, 1976
34. Elion GB: Biochemistry and pharmacology of purine analogues. Fed Proc 26: 898–903, 1967